Merck isn't the only pharmaceutical company making an antiviral pill for COVID-19. But Merck's pill is farther along in the process and could become the first antiviral drug approved to be taken ...

Merck (MRK) shareholders are grumbling that they're being charged $20 for new Merck shares that are identical to the old ones in the merger with Schering-Plough. That's because Merck's lawyers ...

New Merck R&D chief Roger Perlmutter already has shaken up the drug maker's labs and plans more changes, including reducing the number of research projects in which the company invests.

A new Covid-19 pill from Merck & Co. and Ridgeback Biotherapeutics LP has been more widely used than expected since rolling out late last year, though regulators and many doctors consider it a ...

Merck’s adjusted profit of $5.4 billion in Q3 2023 reflected a 15% growth from its $4.7 billion profit figure in the prior-year quarter. The adjusted profit of $2.13 per share was higher than ...

Merck says it expects to begin that study late this year or in early 2024. Prometheus has said that PRA023’s ability to address both inflammation and fibrosis offers the potential for expanding ...

Merck & Co Inc on Thursday said its experimental COVID-19 drug could bring in between $5 billion and $7 billion in sales through the end of next year, assuming it gains U.S. authorization in December.

Merck & Co sued the U.S. government on Tuesday, seeking to halt the Medicare drug price negotiation program contained in the Inflation Reduction Act (IRA), which it argues violates the Fifth and ...

The U.S. government has agreed to pay Merck $1.2 billion for 1.7 million courses of an experimental COVID-19 treatment if the drug works and is approved by regulators.

At Merck’s investor day in May 2021, the management predicted $6.1 billion to $6.4 billion of 2021 revenue for Organon, and annual sales increases in single-digits, referred to by CEO Kevin Ali ...

Merck's dividend story is also better-than-usual when measured against Big Pharma peers. The upfront yield has risen from 2.4% a year ago to 4.1% today (on a forward projected basis), which is now ...